TY - JOUR
T1 - In vitro production of cytokines is influenced by sulfatide and its precursor galactosylceramide
AU - Bovin, L F
AU - Fredman, P
AU - Månsson, J E
AU - Buschard, K
AU - Bendtzen, K
PY - 1999/7/23
Y1 - 1999/7/23
N2 - Effects of sulfatide and its precursor galactosylceramide (gal-cer) on the kinetics of production of cytokines were studied. In human mononuclear leucocytes, gal-cer but not sulfatide induced significantly increased amounts of interleukin (IL)-1beta, IL-6 and tumor necrosis factor (TNF) mRNA. In phytohemagglutinin-stimulated cultures, gal-cer increased the levels of IL-1beta and IL-6 mRNA and secreted IL-1beta and IL-6, while sulfatide decreased the amounts of IL-6 mRNA and secreted IL-6. Gal-cer also increased TNF secretion. In lipopolysaccharide-stimulated cells, sulfatide but not gal-cer decreased the secretion of IL-1beta and IL-10, a potent suppressor of production of many cytokines. Thus, sulfatide and gal-cer affect cytokine production differently, most likely at the level of gene expression. This may have implications in diseases where inflammatory cytokines play a pathogenic role.
AB - Effects of sulfatide and its precursor galactosylceramide (gal-cer) on the kinetics of production of cytokines were studied. In human mononuclear leucocytes, gal-cer but not sulfatide induced significantly increased amounts of interleukin (IL)-1beta, IL-6 and tumor necrosis factor (TNF) mRNA. In phytohemagglutinin-stimulated cultures, gal-cer increased the levels of IL-1beta and IL-6 mRNA and secreted IL-1beta and IL-6, while sulfatide decreased the amounts of IL-6 mRNA and secreted IL-6. Gal-cer also increased TNF secretion. In lipopolysaccharide-stimulated cells, sulfatide but not gal-cer decreased the secretion of IL-1beta and IL-10, a potent suppressor of production of many cytokines. Thus, sulfatide and gal-cer affect cytokine production differently, most likely at the level of gene expression. This may have implications in diseases where inflammatory cytokines play a pathogenic role.
KW - Adult
KW - Cytokines/biosynthesis
KW - Galactosylceramides/pharmacology
KW - Humans
KW - In Vitro Techniques
KW - Inflammation Mediators/metabolism
KW - Interleukin-1/biosynthesis
KW - Interleukin-6/biosynthesis
KW - Leukocytes, Mononuclear/drug effects
KW - Lipopolysaccharides/pharmacology
KW - Phytohemagglutinins/pharmacology
KW - RNA, Messenger/genetics
KW - Sulfoglycosphingolipids/pharmacology
KW - Tumor Necrosis Factor-alpha/biosynthesis
U2 - 10.1016/s0014-5793(99)00908-4
DO - 10.1016/s0014-5793(99)00908-4
M3 - Journal article
C2 - 10437800
SN - 0014-5793
VL - 455
SP - 339
EP - 343
JO - FEBS Letters
JF - FEBS Letters
IS - 3
ER -